THE EPSTEIN-BARR-VIRUS BZLF1 GENE-PRODUCT ACTIVATES THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 5' LONG TERMINAL REPEAT

被引：36

作者：

MALLON, R ^{[1
]}

BORKOWSKI, J ^{[1
]}

ALBIN, R ^{[1
]}

PEPITONI, S ^{[1
]}

SCHWARTZ, J ^{[1
]}

KIEFF, E ^{[1
]}

机构：

[1] HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115

来源：

JOURNAL OF VIROLOGY | 1990年 / 64卷 / 12期

关键词：

D O I：

10.1128/JVI.64.12.6282-6285.1990

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：6282 / 6285

页数：4

共 25 条

[1] INCREASED EPSTEIN-BARR VIRUS-DNA IN OROPHARYNGEAL SECRETIONS FROM PATIENTS WITH AIDS, AIDS-RELATED COMPLEX, OR ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTIONS [J].

ALSIP, GR ;

ENCH, Y ;

SUMAYA, CV ;

BOSWELL, RN .

JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :1072-1076

[2] DEFECTIVE REGULATION OF EPSTEIN-BARR VIRUS-INFECTION IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) OR AIDS-RELATED DISORDERS [J].

BIRX, DL ;

REDFIELD, RR ;

TOSATO, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (14) :874-879

[3] ELECTROPORATION FOR THE EFFICIENT TRANSFECTION OF MAMMALIAN-CELLS WITH DNA [J].

CHU, G ;

HAYAKAWA, H ;

BERG, P .

NUCLEIC ACIDS RESEARCH, 1987, 15 (03) :1311-1326

[4] AN ENHANCER WITHIN THE DIVERGENT PROMOTER OF EPSTEIN-BARR VIRUS RESPONDS SYNERGISTICALLY TO THE R-TRANSACTIVATORS AND Z-TRANSACTIVATORS [J].

COX, MA ;

LEAHY, J ;

HARDWICK, JM .

JOURNAL OF VIROLOGY, 1990, 64 (01) :313-321

[5] TRANSACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS OCCURS VIA A BIMODAL MECHANISM [J].

CULLEN, BR .

CELL, 1986, 46 (07) :973-982

[6] IMMEDIATE-EARLY GENE REGION OF HUMAN CYTOMEGALOVIRUS TRANS-ACTIVATES THE PROMOTER OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].

DAVIS, MG ;

KENNEY, SC ;

KAMINE, J ;

PAGANO, JS ;

HUANG, ES .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8642-8646

[7] EPSTEIN-BARR VIRUS BZLF1 TRANS-ACTIVATOR SPECIFICALLY BINDS TO A CONSENSUS AP-1 SITE AND IS RELATED TO C-FOS [J].

FARRELL, PJ ;

ROWE, DT ;

ROONEY, CM ;

KOUZARIDES, T .

EMBO JOURNAL, 1989, 8 (01) :127-132

[8] ACQUIRED IMMUNODEFICIENCY SYNDROME - EPIDEMIOLOGIC, CLINICAL, IMMUNOLOGICAL, AND THERAPEUTIC CONSIDERATIONS [J].

FAUCI, AS ;

MACHER, AM ;

LONGO, DL ;

LANE, HC ;

ROOK, AH ;

MASUR, H ;

GELMANN, EP .

ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) :92-106

[9] HIV-1 TAT TRANS-ACTIVATION REQUIRES THE LOOP SEQUENCE WITHIN TAR [J].

FENG, S ;

HOLLAND, EC .

NATURE, 1988, 334 (6178) :165-167

[10] A CIS-ACTING ELEMENT WITHIN THE 5' LEADER OF A CYTOMEGALOVIRUS BETA-TRANSCRIPT DETERMINES KINETIC CLASS [J].

GEBALLE, AP ;

SPAETE, RR ;

MOCARSKI, ES .

CELL, 1986, 46 (06) :865-872

← 1 2 3 →